Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.

NCT01831466 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01831466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01831466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2014
Enrollment
476 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriasis vulgaris